Sabinsa (East Windsor, NJ) has acquired ayurvedic products brand Nature’s Formulary, and named that company’s founder and president, P K Davé, as CEO of Sabinsa’s Consumer Goods Division, focusing on wellness products to include the America’s Finest, Inc (AFI), Nature’s Formulary, and Sanutra Wellness brands.

“We are thrilled to welcome Nature’s Formulary into the Sabinsa family,” said Shaheen Majeed, MBA, DLitt, global CEO and managing director, Sami-Sabinsa Group. “This acquisition represents a significant milestone in our long-term strategy to further strengthen Sabinsa’s leadership in the natural products industry. By integrating Nature’s Formulary’s expertise in ayurvedic formulations with Sabinsa’s advanced research and development capabilities, we are uniquely positioned to drive innovation and continue to deliver high-quality, transformative wellness solutions to our global customer base for years to come.”

 “This acquisition is a direct reflection of the dedication and hard work of the entire Nature’s Formulary team,” said P K Davé. “Partnering with Sabinsa presents an incredible opportunity to leverage their global presence and robust infrastructure, while significantly expanding Nature’s Formulary’s impact in the dietary supplement industry. We are confident that our combined strengths will accelerate our mission to promote holistic health and wellness through ayurvedic products. Together, we will unlock new opportunities and create lasting value for our loyal customers and partners worldwide. We can leverage the presence of Nature’s Formulary in health food stores to tell the Sabinsa story, bringing our products to an even wider audience and deepening the impact of our combined vision for natural health solutions.”

For more information, visit https://sabinsa.com.